CMRE has published Situation épidémiologique du 08 décembre 2019. Excerpt from the Google translation:
EVOLUTION OF THE EPIDEMIC IN THE PROVINCES OF NORTH KIVU AND ITURI AT 07 DECEMBER 2019
Sunday, December 08, 2019
Since the beginning of the epidemic, the cumulative number of cases is 3,320, of which 3,202 are confirmed and 118 are probable. In total, there were 2,209 deaths (2091 confirmed and 118 probable) and 1084 people healed.
• 391 suspected cases under investigation;
• 4 suspected cases were notified on 05 December 2019 in the Osso health area in Lubutu, Maniema province. 1 case was invalidated. Among the 3 remaining suspects, the first samples of 2 suspects are negative and their clinical evolution is good. They are in agreement of the second levy. One suspect died and the oral sample was not taken and the body was secured and returned to the family.
• 1 new confirmed cases in North Kivu in Mabalako;
• No new deaths among confirmed cases;
• No cured person has emerged from CTEs;
• No health worker is among the new confirmed cases. The cumulative number of confirmed / probable cases among health workers is 164 (5% of all confirmed / probable cases), including 41 deaths;
• Ebola response activities are paralyzed in Beni, Mangina and Biakato sub-coordination for security reasons;
The data presented in this table are subject to change after extensive investigation and after redistribution of cases and deaths in their respective health areas.
NEWS
Joint DRC-Rwanda launch of the second Johnson and Johnson vaccine in Rubavu, Rwanda
• The official launch of the second Ebola vaccine took place on Sunday, 08 December 2019 in Rubavu, Rwanda, precisely on the border between the Democratic Republic of Congo and the Republic of Rwanda;
• Launched jointly by the two countries as part of regional protection against Ebola Virus Disease, the International Health Regulations make cross-border relations one of its priorities;
• WHO declared on July 17, 2019 in Geneva, this tenth outbreak of Ebola Virus Disease as a health emergency of international concern;
• For the Technical Secretary of the CMRE, Prof. Jean-Jacques Muyembe Ntamfum, this joint launch will help strengthen regional and international health security in the immunization component;
• The DRC has already started vaccinating its Majengo and Kahembe populations in the health zone of Karisimbi in the city of Goma and since November 14, 2019 more than 1300 people have been vaccinated;
• The launch of the second J & J vaccine was made in front of the Deputy Governor of North Kivu Province accompanied by his provincial Minister of Health, the General Coordinator of the Epidemic Response to Ebola Virus Disease and various partners including a representative of the World Health Organization (WHO) and a representative of Johnson and Johnson;
• For this launch in Rwanda, the first person to receive the second vaccine, is a Congolese, a collaborator of Prof. Muyembe, who welcomed this dose that protects him against the Ebola virus. To this end, he invited other persons from Rwanda and the Democratic Republic of the Congo to follow his example;
• For the Rwandan Minister of Health, Dr. Diane Gashumba, it is very important to seize this opportunity during this time when the epidemic continues to make victims in the DRC to vaccinate their population in order to save them from possible epidemics. This vaccination, for Rwanda, is conducted by the Organization "Umurinzi", which means "the guardian";
• The J & J launch ceremony was closed with a press conference hosted by the Technical Secretary of the Multisectoral Ebola Virus Epidemic Committee and the Minister of Health of the Republic of Rwanda;
• As soon as the Technical Secretary of the CMRE left Rwanda, he went directly to the health center, where are hospitalized the wounded returned from Biakato following the attacks by armed incivists on the night of 27 to 28 November 2019 ;
• There are a total of 7, including 6 men and 1 woman, who have said they are ready to resume their life-saving work, especially saving lives, especially those who are sick with Ebola.
VACCINATION
• 1300 people were vaccinated, until 06 December 2019, with the 2nd Ad26.ZEBOV / MVA-BN-Filo vaccine (Johnson & Johnson) in the two health zones of Karisimbi in Goma;
• Since the start of vaccination on August 8, 2018 with the rVSV-ZEBOV vaccine, 256,229 people have been vaccinated;
• Approved October 22, 2019 by the Ethics Committee of the School of Public Health of the University of Kinshasa and October 23, 2019 by the National Ethics Committee, the second vaccine, called Ad26.ZEBOV / MVA-BN -Filo, is produced by Janssen Pharmaceuticals for Johnson & Johnson;
• This new vaccine complements the first, the rVSV-ZEBOV, vaccine used until then (since August 08, 2018) in this epidemic manufactured by the pharmaceutical group Merck, after approval of the Ethics Committee on May 20, 2018. It has recently been pre-qualified for registration.
MONITORING AT ENTRY POINTS
• Sanitary control activities were resumed in the various entry and control points of the Beni and Mangina sub-coordinations in North Kivu;
• Health control activities are disrupted in the Biakato Sub-Coordinations in Ituri;
• Since the beginning of the epidemic, the total number of travelers checked (temperature increase) at the sanitary control points, until Wednesday 05 December 2019, is 123,984,301 ;
• To date, a total of 109 entry points (PoE) and sanitary control points (PoCs) have been set up in the provinces of North Kivu and Ituri to protect the country's major cities and prevent the spread of the epidemic in neighboring countries.
